It is a clinical trail to observe the efficacy of two drugs(morphine and ketorolac) in severe vaso occlusive pain crisis(pain management) in sickle cell disease children.

Phase 2

• Conditions: Health Condition 1: D570- Hb-SS disease with crisis

• Registration Number: CTRI/2021/01/030300
• Lead Sponsor: AIIMSRaipur

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

All children diagnosed with severe vaso occlusive crisis sickle cell disease aged 3 To 15 years.

Exclusion Criteria

children with age less than 3 years and age more than 15years.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
pain score will be evaluated every 3rd hourly after starting of infusion ,if anytime pain score less than or equal to 6 for next 6 hours on same infusion rate is considered as responders.Timepoint: 3,6,9,12hours of infusion

Secondary Outcome Measures

Name	Time	Method
if pain score greater than 6 hours even after 12 hours of infusion, they considered as non respondersTimepoint: 3,6,12 hours.